Christopher Cowles

Christopher R. Cowles

Opinion author

Christopher R. Cowles, PhD, is a partner at Withers Bergman LLP with decades of experience providing IP counsel to biotech and high-tech startups, companies and institutions, as well as to VC and family office technology investors, leading a legally and scientifically rigorous patent prosecution team to optimize client outcomes.

The recent invalidation of an AAV gene therapy patent overlooks the complexity of innovation in biotechnology and could put a broad swath of intellectual property at risk.